Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor
A non-integrated induced pluripotent stem cell (iPSC) line was established using urine cells (UCs) derived from a healthy 32-year-old male. The patient-derived iPSC line SMBCi006-A exhibited a normal karyotype, expressed pluripotency markers and possessed trilineage differentiation potential. This c...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506120303263 |
id |
doaj-3bcbf14327be4ce59e13674dcd935bcc |
---|---|
record_format |
Article |
spelling |
doaj-3bcbf14327be4ce59e13674dcd935bcc2020-12-19T05:04:52ZengElsevierStem Cell Research1873-50612020-12-0149102025Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donorLiang Shi0Yazhou Cui1Genglin Zhang2Xiaoyan Zhou3Jing Luan4Jinxiang Han5Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, ChinaDepartment of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan 250014, Shandong, China; Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji’nan 250062, Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji’nan 250062, Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji’nan 250062, Shandong, China; Corresponding author at: Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji’nan, Shandong, China.A non-integrated induced pluripotent stem cell (iPSC) line was established using urine cells (UCs) derived from a healthy 32-year-old male. The patient-derived iPSC line SMBCi006-A exhibited a normal karyotype, expressed pluripotency markers and possessed trilineage differentiation potential. This cell line may serve as a basis for disease modeling, and help explore the molecular pathogenesis further.http://www.sciencedirect.com/science/article/pii/S1873506120303263 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Liang Shi Yazhou Cui Genglin Zhang Xiaoyan Zhou Jing Luan Jinxiang Han |
spellingShingle |
Liang Shi Yazhou Cui Genglin Zhang Xiaoyan Zhou Jing Luan Jinxiang Han Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor Stem Cell Research |
author_facet |
Liang Shi Yazhou Cui Genglin Zhang Xiaoyan Zhou Jing Luan Jinxiang Han |
author_sort |
Liang Shi |
title |
Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor |
title_short |
Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor |
title_full |
Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor |
title_fullStr |
Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor |
title_full_unstemmed |
Establishment of a control induced pluripotent stem cell line SMBCi006-A from a healthy male donor |
title_sort |
establishment of a control induced pluripotent stem cell line smbci006-a from a healthy male donor |
publisher |
Elsevier |
series |
Stem Cell Research |
issn |
1873-5061 |
publishDate |
2020-12-01 |
description |
A non-integrated induced pluripotent stem cell (iPSC) line was established using urine cells (UCs) derived from a healthy 32-year-old male. The patient-derived iPSC line SMBCi006-A exhibited a normal karyotype, expressed pluripotency markers and possessed trilineage differentiation potential. This cell line may serve as a basis for disease modeling, and help explore the molecular pathogenesis further. |
url |
http://www.sciencedirect.com/science/article/pii/S1873506120303263 |
work_keys_str_mv |
AT liangshi establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor AT yazhoucui establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor AT genglinzhang establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor AT xiaoyanzhou establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor AT jingluan establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor AT jinxianghan establishmentofacontrolinducedpluripotentstemcelllinesmbci006afromahealthymaledonor |
_version_ |
1724377968135897088 |